AAAAAA
Results:
1-22
|
Results: 22
Authors:
SRINIVAS RV
FRIDLAND A
Citation: Rv. Srinivas et A. Fridland, ANTIVIRAL ACTIVITIES OF 9-R-2-PHOSPHONOMETHOXYPROPYL ADENINE (PMPA) AND BIS(ISOPROPYLOXYMETHYLCARBONYL)PMPA AGAINST VARIOUS DRUG-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS STRAINS, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1484-1487
Authors:
ROBBINS BL
SRINIVAS RV
KIM C
BISCHOFBERGER N
FRIDLAND A
Citation: Bl. Robbins et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY AND CELLULAR-METABOLISM OFA POTENTIAL PRODRUG OF THE ACYCLIC NUCLEOSIDE PHOSPHONATE 9-R-(2-PHOSPHONOMETHOXYPROPYL)ADENINE (PMPA), BIS(ISOPROPYLOXYMETHYLCARBONYL)PMPA, Antimicrobial agents and chemotherapy, 42(3), 1998, pp. 612-617
Authors:
ROBBINS BL
TRAN TT
PINKERTON FH
AKEB F
GUEDJ R
GRASSI J
LANCASTER D
FRIDLAND A
Citation: Bl. Robbins et al., DEVELOPMENT OF A NEW CARTRIDGE RADIOIMMUNOASSAY FOR DETERMINATION OF INTRACELLULAR LEVELS OF LAMIVUDINE TRIPHOSPHATE IN THE PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS, Antimicrobial agents and chemotherapy, 42(10), 1998, pp. 2656-2660
Authors:
GIRARD F
LEE MG
AGROFOGLIO LA
FRIDLAND A
Citation: F. Girard et al., A SHORT AND STEREOSELECTIVE SYNTHESIS OF CARBOCYCLIC ALPHA-L-DIDEOXYHOMONUCLEOSIDES, Journal of heterocyclic chemistry, 35(4), 1998, pp. 911-913
Authors:
SRINIVAS RV
CONNELY M
FRIDLAND A
Citation: Rv. Srinivas et al., S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE (HPMPC) INHIBITS HIV-1 REPLICATION IN EPITHELIAL-CELLS, BUT NOT T-LYMPHOCYTES, Antiviral research, 35(1), 1997, pp. 23-27
Authors:
TANAKA M
SRINIVAS RV
UENO T
KAVLICK MF
HUI FK
FRIDLAND A
DRISCOLL JS
MITSUYA H
Citation: M. Tanaka et al., IN-VITRO INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS RESISTANT TO 2'-BETA-FLUORO-2',3'-DIDEOXYADENOSINE, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1313-1318
Authors:
PISAREV VM
LEE SH
CONNELLY MC
FRIDLAND A
Citation: Vm. Pisarev et al., INTRACELLULAR METABOLISM AND ACTION OF ACYCLIC NUCLEOSIDE PHOSPHONATES ON DNA-REPLICATION, Molecular pharmacology, 52(1), 1997, pp. 63-68
Authors:
RODMAN JH
ROBBINS BL
FLYNN PM
FRIDLAND A
Citation: Jh. Rodman et al., MATERNAL AND FETAL PHARMACOKINETICS (PK) OF ZIDOVUDINE (ZDV), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 67-67
Authors:
ROBBINS BL
WAIBEL BH
FRIDLAND A
Citation: Bl. Robbins et al., QUANTITATION OF INTRACELLULAR ZIDOVUDINE PHOSPHATES BY USE OF COMBINED CARTRIDGE RADIOIMMUNOASSAY METHODOLOGY, Antimicrobial agents and chemotherapy, 40(11), 1996, pp. 2651-2654
Authors:
RODMAN JH
ROBBINS B
FLYNN PM
FRIDLAND A
Citation: Jh. Rodman et al., A SYSTEMIC AND CELLULAR-MODEL FOR ZIDOVUDINE PLASMA-CONCENTRATIONS AND INTRACELLULAR PHOSPHORYLATION IN PATIENTS, The Journal of infectious diseases, 174(3), 1996, pp. 490-499
Authors:
FRIDLAND A
ADUMA P
SRINIVAS RV
Citation: A. Fridland et al., STUDY OF HUMAN-IMMUNODEFICIENCY-VIRUS RESISTANCE TO THE ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 11-11
Authors:
SRINIVAS RV
GONG YF
BECHER A
FRIDLAND A
Citation: Rv. Srinivas et al., MODULATORS OF NUCLEOTIDE-METABOLISM INHIBIT HIV REPLICATION IN LYMPHOID-CELLS AND AFFECT ITS INHIBITION BY DIDEOXYNUCLEOSIDES, Nucleosides & nucleotides, 14(3-5), 1995, pp. 641-644
Authors:
ROBBINS BL
GREENHAW J
CONNELLY MC
FRIDLAND A
Citation: Bl. Robbins et al., METABOLIC PATHWAYS FOR ACTIVATION OF THE ANTIVIRAL AGENT 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE IN HUMAN LYMPHOID-CELLS, Antimicrobial agents and chemotherapy, 39(10), 1995, pp. 2304-2308
Authors:
ADUMA P
CONNELLY MC
SRINIVAS RV
FRIDLAND A
Citation: P. Aduma et al., METABOLIC DIVERSITY AND ANTIVIRAL ACTIVITIES OF ACYCLIC NUCLEOSIDE PHOSPHONATES, Molecular pharmacology, 47(4), 1995, pp. 816-822
Authors:
ROBBINS BL
CONNELLY MC
MARSHALL DR
SRINIVAS RV
FRIDLAND A
Citation: Bl. Robbins et al., A HUMAN T-LYMPHOID CELL VARIANT RESISTANT TO THE ACYCLIC NUCLEOSIDE PHOSPHONATE 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE SHOWS A UNIQUE COMBINATION OF A PHOSPHORYLATION DEFECT AND INCREASED EFFLUX OF THE AGENT, Molecular pharmacology, 47(2), 1995, pp. 391-397
Authors:
GONG YF
MARSHALL DR
SRINIVAS RV
FRIDLAND A
Citation: Yf. Gong et al., SUSCEPTIBILITIES OF ZIDOVUDINE-RESISTANT VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TO INHIBITION BY ACYCLIC NUCLEOSIDE PHOSPHONATES, Antimicrobial agents and chemotherapy, 38(7), 1994, pp. 1683-1687
Authors:
ROBBINS BL
RODMAN J
MCDONALD C
SRINIVAS RV
FLYNN PM
FRIDLAND A
Citation: Bl. Robbins et al., ENZYMATIC ASSAY FOR MEASUREMENT OF ZIDOVUDINE TRIPHOSPHATE IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS, Antimicrobial agents and chemotherapy, 38(1), 1994, pp. 115-121
Authors:
ROBBINS BL
MCDONALD C
HOLDEN W
FLYNN PM
SRINIVAS RV
FRIDLAND A
Citation: Bl. Robbins et al., A NOVEL METHOD FOR THE MEASUREMENT OF INTRACELLULAR ZIDOVUDINE TRIPHOSPHATE (ZDV-TP), Journal of cellular biochemistry, 1993, pp. 22-22
Authors:
SRINIVAS RV
ROBBINS BL
CONNELLY MC
GONG YF
BISCHOFBERGER N
FRIDLAND A
Citation: Rv. Srinivas et al., METABOLISM AND IN-VITRO ANTIRETROVIRAL ACTIVITIES OF BIS(PIVALOXYLOXYMETHYL) PRODRUGS OF ACYCLIC NUCLEOSIDE PHOSPHONATES, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2247-2250
Authors:
GONG YF
SRINIVAS RV
FRIDLAND A
Citation: Yf. Gong et al., 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE POTENTIATES THE METABOLISM AND ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY OF 2',3'-DIDEOXYINOSINE, Molecular pharmacology, 44(1), 1993, pp. 30-36
Authors:
BALZARINI J
KARLSSON A
WANG LY
BOHMAN C
HORSKA K
VOTRUBA I
FRIDLAND A
VANAERSCHOT A
HERDEWIJN P
DECLERCQ E
Citation: J. Balzarini et al., EICAR NYL-1-BETA-D-RIBOFURANOSYLIMIDAZOLE-4-CARBOXAMIDE) - A NOVEL POTENT INHIBITOR OF INOSINATE DEHYDROGENASE-ACTIVITY AND GUANYLATE BIOSYNTHESIS, The Journal of biological chemistry, 268(33), 1993, pp. 24591-24598
Authors:
CONNELLY MC
ROBBINS BL
FRIDLAND A
Citation: Mc. Connelly et al., MECHANISM OF UPTAKE OF THE PHOSPHONATE ANALOG S)-1-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)CYTOSINE (HPMPC) IN VERO CELLS, Biochemical pharmacology, 46(6), 1993, pp. 1053-1057
Risultati:
1-22
|